These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7061183)

  • 1. Electrocardiographic changes after long-term treatment with sotalol in hypertensive patients.
    Castro M; Descamps R; Thomis JA
    Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):88-91. PubMed ID: 7061183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Electrocardiographic changes in patients with chronic anemia].
    Stanojević M; Stankov S
    Srp Arh Celok Lek; 1998; 126(11-12):461-6. PubMed ID: 9921020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sotalol, propafenone, and flecainide: compared multiparametric analysis of ventricular repolarization in subjects without organic cardiopathy].
    Sarubbi B; Ducceschi V; Briglia N; Esposito R; Mayer MS; Scialdone A; Santangelo L; Iacono A
    Cardiologia; 1996 Jul; 41(7):645-51. PubMed ID: 8983831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of arterial hypertension with sotalol, a beta-blocker (author's transl)].
    Klein G; Schnelle K; Schinz A; Oberländer V
    Dtsch Med Wochenschr; 1977 Apr; 102(15):563-9. PubMed ID: 849711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ECG changes during long-term minoxidil therapy for severe hypertension.
    Hall D; Charocopos F; Froer KL; Rudolph W
    Arch Intern Med; 1979 Jul; 139(7):790-4. PubMed ID: 36861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypotensive effect of sotalol under basic conditions and during exercise. Clinical cases].
    Gamna G; Biasci R; Avogliero G; Garrone M; Montrucchio G; Pascale C
    Minerva Med; 1983 Oct; 74(40):2389-93. PubMed ID: 6657106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rate dependence of sotalol-induced prolongation of ventricular repolarization during exercise in humans.
    Funck-Brentano C; Kibleur Y; Le Coz F; Poirier JM; Mallet A; Jaillon P
    Circulation; 1991 Feb; 83(2):536-45. PubMed ID: 1846784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of change in posture and exercise on repolarization in patients with long QT syndrome with HERG channel mutations.
    Walker BD; Krahn AD; Klein GJ; Skanes AC; Yee R; Wang J; Hegele RA
    Can J Cardiol; 2005 Jan; 21(1):33-8. PubMed ID: 15685300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating the effect of sotalol on the repolarization intervals in healthy young individuals.
    Couderc JP; Zhou M; Sarapa N; Zareba W
    J Electrocardiol; 2008; 41(6):595-602. PubMed ID: 18801493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sotalol prolongation of the QTc interval in hypertensive patients.
    Neuvonen PJ; Elonen E; Tanskanen A; Tuomilehto J
    Clin Pharmacol Ther; 1982 Jul; 32(1):25-32. PubMed ID: 7083728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M; Richter WO; Schwandt P; Holzgreve H
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sotalol vs metoprolol for ventricular rate control in patients with chronic atrial fibrillation who have undergone digitalization: a single-blinded crossover study.
    Kochiadakis GE; Kanoupakis EM; Kalebubas MD; Igoumenidis NE; Vardakis KE; Mavrakis HE; Vardas PE
    Europace; 2001 Jan; 3(1):73-9. PubMed ID: 11271956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of QTc dispersion by the angiotensin II receptor blocker valsartan may be related to its anti-oxidative stress effect in patients with essential hypertension.
    Miyajima K; Minatoguchi S; Ito Y; Hukunishi M; Matsuno Y; Kakami M; Kawasaki M; Nishigaki K; Takemura G; Fujiwara H
    Hypertens Res; 2007 Apr; 30(4):307-13. PubMed ID: 17541209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Plasma level and action of sotalol-HCL on the ECG interval after parenteral administration in healthy subjects].
    Rehm KD; Schnelle K; Dyde CJ; Blümner E; Arendts W
    Arzneimittelforschung; 1987 Sep; 37(9):1058-62. PubMed ID: 3435602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [QT interval dispersion in hypertensive diabetics and in patients with hypertension with chronic heart failure without diabetes].
    Radman A; Murín J; Bulas J; Reptová A; Ravingerová T; Mikes P; Kozliková K; Ghanem W; Jaber J; Baqi L
    Vnitr Lek; 2003 Oct; 49(10):802-7. PubMed ID: 14682153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QT hysteresis in long-QT syndrome children with exercise testing.
    Gao DS; Fang WY; Chiu-Man C; Kirsh J; Gross G; Hamilton RM
    Chin Med J (Engl); 2007 Feb; 120(3):179-82. PubMed ID: 17355817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
    J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis of long QT syndrome with the help of atropine provoked ventricular tachycardia].
    Galatius-Jensen S; Clemmensen PM; Pietersen AH; Nielsen HV
    Ugeskr Laeger; 1994 Jan; 156(5):657-8. PubMed ID: 8184501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prazosin enhances the antihypertensive effects of beta-blockers during isometric and dynamic exercise.
    Aärynen M; Mäkelä M; Hämeenaho P; Mattila MJ
    Ann Clin Res; 1981 Apr; 13(2):71-6. PubMed ID: 7015988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of treatment with somatostatin analogues on QT interval duration in acromegalic patients.
    Fatti LM; Scacchi M; Lavezzi E; Pecori Giraldi F; De Martin M; Toja P; Michailidis G; Stramba-Badiale M; Cavagnini F
    Clin Endocrinol (Oxf); 2006 Nov; 65(5):626-30. PubMed ID: 17054464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.